POSSIBLE CLINICAL EFFECTS OF THE INTERACTION OF HEMODIALYSIS MEMBRANES WITH ADHESION PROTEINS

被引:6
作者
BAUMGARTNERPARZER, SM
SEYFERT, UT
MANNHALTER, C
机构
[1] UNIV VIENNA, CLIN INST MED CHEM & LAB DIAGNOST, VIENNA, AUSTRIA
[2] UNIV HOSP HOMBURG SAAR, DEPT CLIN HEAMOSTASEOL & TRANSFUS MED, HOMBURG, GERMANY
[3] UNIV VIENNA, DEPT INTERNAL MED 3, DIV ENDOCRINOL & METAB, A-1090 VIENNA, AUSTRIA
关键词
D O I
10.1038/ki.1995.159
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Possible clinical effects of the interaction of hemodialysis membranes with adhesion proteins. In this study data obtained in an in vitro hemodialysis model are related to various parameters measured in patients' plasma during hemodialysis in a clinical crossover study. In vitro, blood from healthy volunteers was dialyzed under standardized conditions using the capillaries Fresenius MTS C (Cuprophane) and Hospal AN 69 (Polyacrylonitrile). Following dialysis, surface bound proteins were eluted with saline, 1 M Tris and 2% SDS, and analyzed by immunoblotting. Depending on the capillary, different protein patterns could be identified in the eluates. Intact forms of adhesion proteins were predominantly (fibrinogen) or exclusively (vitronectin) found in PA eluates. In contrast, low molecular weight products of fibrinogen as well as high molecular weight components containing antithrombin III (AT III) were present in CP eluates. Their presence may reflect fibrinolytic and procoagulatory activity during dialysis with CP capillaries. A microscopic investigation of CP membranes demonstrated fibrin lined platelet conglomerates. In the plasmas of patients dialyzed with CP capillaries high D-Dimer concentrations were found. We also noticed that during dialysis with PA membranes less heparin was consumed than during dialysis with CP membranes. Our study showed a good correlation of the observations in the in vitro system and the measurements in patient samples.
引用
收藏
页码:1115 / 1120
页数:6
相关论文
共 27 条
  • [1] ADDONIZIO VP, 1979, BLOOD, V53, P1033
  • [2] BALE MD, 1989, BLOOD, V74, P2698
  • [3] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN FOR POST-TRANSFUSION PURPURA
    BECKER, T
    PANZER, S
    MAAS, D
    KIEFEL, V
    SPRENGER, R
    KIRSCHBAUM, M
    MUELLERECKHARDT, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (01) : 149 - 155
  • [4] BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
  • [5] ANAPHYLATOXIN FORMATION DURING HEMODIALYSIS - EFFECTS OF DIFFERENT DIALYZER MEMBRANES
    CHENOWETH, DE
    CHEUNG, AK
    HENDERSON, LW
    [J]. KIDNEY INTERNATIONAL, 1983, 24 (06) : 764 - 769
  • [6] ANALYSIS OF THE COMPLEMENT C-3 FRAGMENTS ASSOCIATED WITH HEMODIALYSIS MEMBRANES
    CHEUNG, AK
    PARKER, CJ
    JANATOVA, J
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (02) : 576 - 588
  • [7] ACTIVATION OF COMPLEMENT BY HEMODIALYSIS MEMBRANES - POLYACRYLONITRILE BINDS MORE C3A THAN CUPROPHAN
    CHEUNG, AK
    PARKER, CJ
    WILCOX, LA
    JANATOVA, J
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (04) : 1055 - 1059
  • [8] CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
  • [9] GACHON A M F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P263, DOI 10.1163/156856291X00160
  • [10] SPECIFIC GLYCOSAMINOGLYCANS SUPPORT THE INHIBITION OF THROMBIN BY PLASMINOGEN-ACTIVATOR INHIBITOR-1
    GEBBINK, RK
    REYNOLDS, CH
    TOLLEFSEN, DM
    MERTENS, K
    PANNEKOEK, H
    [J]. BIOCHEMISTRY, 1993, 32 (06) : 1675 - 1680